Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Maintenance therapy for colorectal cancer]Shigeo Yamaguchi, Shunsuke KatoGan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2016
[Immune Checkpoint for a Kidney Cancer and Other Cancers]Shunichiro Kageyama, Shigeo Yamaguchi, Kayo Miura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[An Effective Treatment of Relapsed Leiomyosarcoma with Fourth-Line Trabectedin]Yumi Nozaki, Shigeo Yamaguchi, Tatsuya Takagi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Pharmacological Treatment for Bone Metastasis]Shigeo Yamaguchi, Shunichiro Kageyama, Kayo Miura, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|February 23, 2023
Effectiveness of Changing the Class of Molecularly Targeted Agent after Disease Progression during Initial Molecularly Targeted Therapy for Luminal Advanced/Metastatic Breast CancerSatoko Nakano, Akemi Mibu, Shunsuke Kato, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|April 19, 2021
Molecular Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor 2-Negative Metastatic Breast Cancer in Clinical PracticeSatoko Nakano, Yoshimi Imawari, Akemi Mibu, et al.Anticancer Research|April 30, 2022
The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast CancerMin Han, Shigeo Yamaguchi, Mai Onishi, et al.Anticancer Research|May 31, 2024
Identification of BRAF Inhibitor Resistance-associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation ScreeningXuan Wen, Min Han, Masaki Hosoya, et al.International Cancer Conference Journal|June 1, 2019
A case report of using nivolumab for a malignant melanoma patient with rheumatoid arthritisShun-Ichiro Kageyama, Shigeo Yamaguchi, Shin Ito, et al.Anticancer Research|March 28, 2023
TP53 Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast CancerMai Onishi, Shigeo Yamaguchi, Xuan Wen, et al.Pageof 18